Hua Medicine (Shanghai) Ltd.
HKEX:2552.HK
1.15 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1,460.824 | 490.632 | 675.238 | 1,032.09 | 1,105.6 | 1,443.31 | 172.733 | 192.901 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 16.101 | 30 |
| Cash and Short Term Investments
| 1,460.824 | 490.632 | 675.238 | 1,032.09 | 1,105.6 | 1,443.31 | 188.834 | 222.901 |
| Net Receivables
| 0.979 | 12.943 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 44.635 | 1.915 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 42.809 | 418.225 | 29.362 | 13.187 | 14.852 | 31.2 | 43.454 | 1.64 |
| Total Current Assets
| 1,572.477 | 940.257 | 704.6 | 1,045.277 | 1,120.452 | 1,474.51 | 232.288 | 224.541 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 114.538 | 139.708 | 156.6 | 123.518 | 101.474 | 5.328 | 2.641 | 0.878 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 28.572 | 31.952 | 9.026 | 3.387 | 1.98 | 0.859 | 0 | 0 |
| Goodwill and Intangible Assets
| 28.572 | 31.952 | 9.026 | 3.387 | 1.98 | 0.859 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 9.786 | 9.58 | 33.327 | 26.339 | 30.707 | 9.552 | 10.855 | 1.313 |
| Total Non-Current Assets
| 152.896 | 181.24 | 198.953 | 153.244 | 134.161 | 15.739 | 13.496 | 2.191 |
| Total Assets
| 1,725.373 | 1,121.497 | 903.553 | 1,198.521 | 1,254.613 | 1,490.249 | 245.784 | 226.732 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 51.633 | 20.982 | 23.785 | 25.821 | 51.601 | 55.676 | 4.022 | 0.779 |
| Short Term Debt
| 41.471 | 55.413 | 13.296 | 11.503 | 12.019 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -24.279 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 183.209 | 111.991 | 69.803 | 69.223 | 45.166 | 21.957 | 38.975 | 24.502 |
| Total Current Liabilities
| 252.034 | 188.386 | 106.884 | 106.547 | 108.786 | 77.633 | 42.997 | 25.281 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 126.283 | 42.169 | 58.232 | 69.212 | 77.959 | 0 | 1,138.789 | 855.488 |
| Deferred Revenue Non-Current
| 1,245.905 | 611.362 | 288.106 | 290.267 | 7.248 | 9.128 | 6.528 | 12.159 |
| Deferred Tax Liabilities Non-Current
| -1,245.905 | -611.362 | -288.106 | -290.267 | -7.248 | 0 | -1,138.789 | -855.488 |
| Other Non-Current Liabilities
| 1,245.905 | 611.362 | 288.106 | 290.267 | 7.248 | 0 | 1,138.789 | 855.488 |
| Total Non-Current Liabilities
| 1,372.188 | 653.531 | 346.338 | 359.479 | 85.207 | 9.128 | 1,145.317 | 867.647 |
| Total Liabilities
| 1,624.222 | 841.917 | 453.222 | 466.026 | 193.993 | 86.761 | 1,188.314 | 892.928 |
| Equity: | ||||||||
| Preferred Stock
| 6,110.879 | 0 | 0 | 0 | 0 | 4,552 | 949.274 | 676.56 |
| Common Stock
| 7.214 | 7.214 | 7.211 | 7.209 | 7.209 | 7.209 | 0.048 | 0.048 |
| Retained Earnings
| -6,110.879 | -5,899.645 | -5,696.138 | -5,370.404 | -4,977.27 | -4,552 | -949.274 | -676.56 |
| Accumulated Other Comprehensive Income/Loss
| 94.45 | 250.955 | 229.627 | 196.542 | 138.092 | -2.696 | -1.403 | -0.969 |
| Other Total Stockholders Equity
| -0.513 | 5,921.056 | 5,909.631 | 5,899.148 | 5,892.589 | 1,398.975 | -952.525 | -669.221 |
| Total Shareholders Equity
| 101.151 | 279.58 | 450.331 | 732.495 | 1,060.62 | 1,403.488 | -953.88 | -670.142 |
| Total Equity
| 101.151 | 279.58 | 450.331 | 732.495 | 1,060.62 | 1,403.488 | -942.53 | -666.196 |
| Total Liabilities & Shareholders Equity
| 1,725.373 | 1,121.497 | 903.553 | 1,198.521 | 1,254.613 | 1,490.249 | 245.784 | 226.732 |